纤维素玛链基因p.Glu275Lys中的一种新型致病变体导致先天性低纤维素生成症
Miroslava Drotarova1, Rosanna Asselta2,3, Sonia Caccia4
1National Centre of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine and University Hospital Martin, Slovakia.
概括
具有悖论的,先天性低纤维素生成症可能会由于纤维素结构的改变而导致血栓形成. 一种新的FGG基因变异 (p.Glu275Lys) 导致轻度低纤维素生成血和缺血性中风,突出了分子分析的必要性.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 遗传性低纤维素生成性血症具有可变的出血和血栓风险.
- 血栓状表型与纤维素结构和稳定性异常有关.
- 了解这些机制对于诊断和管理至关重要.
研究的目的:
- 为了研究FGG基因中一种新的误解变异的病理生理学.
- 阐明非典型纤维素原乱表现的分子和结构基础.
- 为了将遗传发现与诸如缺血性中风等临床表现相关联.
主要方法:
- 进行了凝血测试.
- 基因分析确定了FGG基因中的致病变体 (c.823G/A,p.Glu275Lys).
- 蛋白质建模可视化了由氨基酸替代引起的结构变化.
主要成果:
- 在FGG基因中发现了一种新的误解变异 (p.Glu275Lys).
- 这种变种会导致轻度的低纤维素生成血症,在临床上呈现为缺血性中风.
- 蛋白质建模显示了轻微的结构变化和影响纤维素聚合的物理化学变化.
结论:
- 这项研究阐明了一种新的FGG基因变异的病理生理学.
- 纤维素原的结构变化可能导致异常的血块形成和血栓形成.
- 分子和结构分析对于管理复杂的纤维素因子疾病至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
532
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
532
Inborn Errors of Metabolism
106
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
106
X-linked Traits
51.3K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
51.3K
Extrinsic and Intrinsic Pathways of Hemostasis
3.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.5K
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638


